- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imaging Dynamics picks up partners
Digital x-ray developer Imaging Dynamics Corp. (IDC) has put together two deals: one a software development and licensing agreement with Analogic, and the other a supply, sales, and service arrangement with fellow Canadian ALI Technologies. Analogic will
Digital x-ray developer Imaging Dynamics Corp. (IDC) has put together two deals: one a software development and licensing agreement with Analogic, and the other a supply, sales, and service arrangement with fellow Canadian ALI Technologies. Analogic will provide image algorithm and processing software that will be integrated into IDC’s Xplorer 1700 digital x-ray system. Specifically, these algorithms address image segmentation and contrast optimization. Conversely, ALI will provide workstation software to be incorporated into Xplorer 1700. ALI will also provide direct sales and service to Imaging Dynamics’ customers for image management and archiving, and will serve as a marketing channel for the Xplorer product.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
